Postmeds, Inc.

Postmeds, Inc. specializes in three primary device categories: capillary blood collection sets for home use, non-insulated specimen container mailers for transporting biological samples, and in vitro diagnostic (IVD) specimen stabilization reagents. These reagents help preserve sample integrity during laboratory testing, ensuring accurate diagnostic results.

Postmeds, Inc. is based in the United States. The provided information does not indicate any international manufacturing or regulatory presence, meaning its devices are primarily regulated under U.S. domestic requirements.

Postmeds, Inc.’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and transparency for Class I devices, which are generally considered low-risk but still subject to regulatory oversight.

Postmeds, Inc.’s devices fall under Class I classification by the FDA. This classification applies to devices posing minimal risk to users, often requiring only general controls (e.g., good manufacturing practices) rather than specialized regulatory scrutiny.

The FDA’s UDI database tracks Class I devices like those from Postmeds, Inc. to ensure traceability, reduce medical errors, and improve supply chain efficiency. While Class I devices typically don’t require premarket approval, UDI listing helps streamline reporting, recalls, and post-market surveillance when needed.